Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-01-02 @ 2:18 PM
Study NCT ID:
NCT04792593
Status:
UNKNOWN
Last Update Posted:
2021-03-11
First Post:
2021-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Senl-h19 CAR-T for B-ALL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None